Ads
related to: remicade dosing guidelines for children- Real Patient Stories
Learn About Actual RINVOQ®
Patient Experiences. Watch Videos.
- Important Safety Info
Read The Full Safety
& Prescribing Info For RINVOQ®.
- Sign Up For More Info
Register For More
Information About RINVOQ®.
- Talk With Your Doctor
Get Talking Tips To Guide
Conversation With Your Doctor.
- Find A Specialist
Find A Doctor
Near You.
- Set Treatment Goals
Talk With Your Doctor About
Setting Goals For Yourself.
- Real Patient Stories
Search results
Results From The WOW.Com Content Network
Clark's rule is a medical term referring to a mathematical formula used to calculate the proper dosage of medicine for children aged 2–17 based on the weight of the patient and the appropriate adult dose. [1] The formula was named after Cecil Belfield Clarke (1894–1970), a Barbadian physician who practiced throughout the UK, the West Indies ...
The selection and use of essential medicines: report of the WHO Expert Committee, 2017 (including the 20th WHO Model List of Essential Medicines and the 6th Model List of Essential Medicines for Children). Geneva: World Health Organization. hdl: 10665/259481. ISBN 978-92-4-121015-7. ISSN 0512-3054. WHO technical report series; no. 1006.
Infliximab, a chimeric monoclonal antibody, sold under the brand name Remicade among others, is a medication used to treat a number of autoimmune diseases. This includes Crohn's disease , ulcerative colitis , rheumatoid arthritis , ankylosing spondylitis , psoriasis , psoriatic arthritis , and Behçet's disease . [ 23 ]
The selection and use of essential medicines. Twentieth report of the WHO Expert Committee 2015 (including 19th WHO Model List of Essential Medicines and 5th WHO Model List of Essential Medicines for Children). Geneva: World Health Organization. 2015. hdl: 10665/189763. ISBN 978-92-4-069494-1. ISSN 0512-3054. WHO technical report series; no. 994.
Children taking this drug may develop bone marrow suppression and an increased susceptibility to infections. [ 65 ] Cyclophosphamide is used at 500 mg per dose for 6 doses every 2 weeks over a one-month period or six 500 to 750 mg intravenous doses per square meter of body surface for 3 years to treat severe cSLE disease and as induction ...
A TNF-α (tumor necrosis factor-alpha) binding protein is a monoclonal antibody or a circulating receptor such as infliximab (Remicade), etanercept (Enbrel), or adalimumab (Humira) that binds to TNF-α, preventing it from inducing the synthesis of IL-1 and IL-6 and the adhesion of lymphocyte-activating molecules.
A child's condition can deteriorate rapidly, even in the presence of reassuring laboratory findings. [21] Many children develop shock and heart failure. [7] Most require paediatric intensive care. [7] Supplemental oxygen is often needed, and mechanical ventilation is sometimes used. [7] Most children who receive expert multidisciplinary care ...
Adalimumab, like infliximab, is an antibody that targets tumor necrosis factor. [18] It has been shown to reduce the signs and symptoms of, and is approved for treatment of, moderate to severe Crohn's disease in adults who have not responded well to conventional treatments and who have lost response to or are unable to tolerate infliximab. [19]
Ad
related to: remicade dosing guidelines for children